Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Inhibin B & Sertoli-Cell Function

The Seminiferous-Tubule Marker the Testosterone Conversation Forgets

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not applicable (endogenous biomarker)

Reference only. Not medical advice.

What can go wrong

Inhibin B is an assay with method-dependent reference ranges and is not a substitute for a semen analysis; it is interpreted alongside FSH and clinical context. A single value should not be over-read.

This is something to take to a clinician. The Atlas can tell you what is known about inhibin b & sertoli-cell function in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Inhibin B is produced by Sertoli cells and provides selective negative feedback on FSH. Because it tracks the function of the seminiferous tubules, serum inhibin B, especially combined with FSH, is a more sensitive marker of spermatogenesis than FSH alone and correlates with sperm concentration. It addresses the half of testicular function that a testosterone level misses entirely.

Testosterone tells you about Leydig cells; inhibin B tells you about sperm.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Assessing spermatogenesis in male-factor infertility
  • Predicting sperm retrieval likelihood in some azoospermia workups
  • Distinguishing tubular from Leydig-cell problems

How it works

Sertoli cells secrete inhibin B in response to FSH and as a function of germ-cell activity; inhibin B then suppresses pituitary FSH. Healthy spermatogenesis is associated with higher inhibin B and lower FSH, while tubular damage drops inhibin B and lets FSH rise. This makes the inhibin B / FSH relationship a window onto sperm production independent of testosterone.

Two compartments, two readouts

The testis has two functional compartments, Leydig cells (testosterone) and Sertoli/germ cells (sperm). A normal testosterone says little about fertility. Exogenous testosterone suppresses LH and FSH, can lower inhibin B, and impairs spermatogenesis even when serum testosterone looks fine, which is why men concerned about fertility should know this marker exists.

What it does to fertility

Inhibin B is itself a fertility marker. Exogenous testosterone and anabolic steroids suppress gonadotropins and can lower inhibin B and sperm production; recovery is variable and a reason fertility-minded men consider hCG or alternatives before TRT.

What has to be monitored

The bloodwork this needs, and the reason it belongs with a clinician rather than a website.

  • Serum inhibin B (assay-specific range)
  • FSH
  • Semen analysis as the clinical reference

What people get wrong

  • Often saidNormal testosterone means normal fertility

    ActuallyNo. Testosterone reflects Leydig-cell output; inhibin B and semen analysis reflect sperm production, which can be impaired independently.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Set against the alternatives

Compared with FSH alone, inhibin B (or the two together) better reflects active spermatogenesis; compared with testosterone, it reports on an entirely different testicular compartment.

At a glance

Source
Sertoli cells
Feedback target
FSH (selective)
Correlation
Positive with sperm concentration; inverse with FSH
Best use
Combined with FSH to assess spermatogenesis

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Inhibin B & Sertoli-Cell Function. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Serum inhibin B as a marker for spermatogenesis2001

    Inhibin B correlated with testicular function and sperm parameters

  • Inhibin B and FSH in impaired spermatogenesis2010

    Combination more sensitive than FSH alone for detecting impaired spermatogenesis